Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01062984 · ClinicalTrials.gov registry record · NA
Continuous Venovenous Hemofiltration Versus Continuous Venovenuous Hemodialysis
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT01062984 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 11 participants.
The verdict
NCT01062984, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
Acute kidney injury is often treated with the use of continuous renal replacement therapy. Two commonly used treatments are continuous venvenous hemofiltration (CVVH)and continuous venovenous hemodialysis (CVVHD). CVVH uses convective clearance to remove toxins and solutes from the patients circulation, while CVVHD relies on diffusive clearance to remove these same toxins/solutes. This study will evaluate which of these two methods is more effective at clearing the body of waste/solutes. We hypothesize that renal replacement therapy by either modality (hemodialysis or hemofiltration; CVVHD or CVVH, respectively) using a modern membrane and higher blood flow rates will be associated with similar clearances of both small and middle molecular weight solutes. We further believe that continuous renal replacement therapy using CVVHD will be associated with decreased clotting events and longer hemofilter survival, as well as improved resource utilization (i.e. nursing time, alarms, etc.).
Interventions
- PROCEDURE Continuous Venovenous Hemofiltration (CVVH)
- PROCEDURE Continuous Venovenous Hemodialysis (CVVHD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2009-01 |
| Est. Completion | 2022-10-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01062984
The ClinicalTrials.gov registry entry for NCT01062984 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Continuous Venovenous Hemofiltration (CVVH) is the first listed.
NCT01062984 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01062984 about?
NCT01062984 is a clinical study titled "Continuous Venovenous Hemofiltration Versus Continuous Venovenuous Hemodialysis". Acute kidney injury is often treated with the use of continuous renal replacement therapy. Two commonly used treatments are continuous venvenous hemofiltration (CVVH)and continuous venovenous hemodialysis (CVVHD). CVVH uses convective clearance to remove toxins and solutes from the patients circulat...
What is the current status of trial NCT01062984?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2009-01. Estimated completion is 2022-10-25.
What interventions are being tested in trial NCT01062984?
The interventions under investigation include: Continuous Venovenous Hemofiltration (CVVH) (PROCEDURE), Continuous Venovenous Hemodialysis (CVVHD) (PROCEDURE).
Who is sponsoring clinical trial NCT01062984?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.